Literature DB >> 25797502

Microwave-assisted synthesis, characterization and cytotoxic studies of novel estrogen receptor α ligands towards human breast cancer cells.

Hanumantharayappa Bharathkumar1, Chakrabhavi Dhananjaya Mohan2, Hanumappa Ananda2, Julian E Fuchs3, Feng Li4, Shobith Rangappa5, Mohan Surender6, Krishna C Bulusu3, Kesturu S Girish7, Gautam Sethi4, Andreas Bender3, Kanchugarakoppal S Rangappa2.   

Abstract

A new, simple, and microwave-assisted, solution-phase T3P®-DMSO mediated method for the preparation of a novel class of estrogen receptor alpha (ERα) ligands based on the 2-phenylquinoline scaffold was developed. Furthermore, the novel ERα ligands were tested for their bioactivity against ERα-positive and ERα-negative cell lines. The ligand (entry 4), with amine and nitro group substitution at C4 position, displayed significant cytotoxicity against MCF-7 and HepG2 cells with an IC50 value of 6 and 11μM, respectively. On the other hand, ERα-negative cells displayed resistance to quinolines induced cytotoxicity with an IC50 value >100Mm and they does not induce cytotoxicity in normal breast epithelial cells. Molecular docking analyses suggest a consistent binding mode for these ERα ligands in the ligand binding domain of the human ERα and predict the ligands to occupy the hydrophobic cavity in a similar fashion as estradiol or GW2368.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Estrogen receptor ligand; Molecular docking; Quinolines; T3P-DMSO mediated synthesis

Mesh:

Substances:

Year:  2015        PMID: 25797502     DOI: 10.1016/j.bmcl.2015.01.030

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Regioselective synthesis and biological studies of novel 1-aryl-3, 5-bis (het) aryl pyrazole derivatives as potential antiproliferative agents.

Authors:  Hanumappa Ananda; Kothanahally S Sharath Kumar; Mayilaadumveettil Nishana; Mahesh Hegde; Mrinal Srivastava; Raghava Byregowda; Bibha Choudhary; Sathees C Raghavan; Kanchugarakoppal S Rangappa
Journal:  Mol Cell Biochem       Date:  2016-11-24       Impact factor: 3.396

Review 2.  Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects.

Authors:  Shailendra Kumar Gangwar; Aviral Kumar; Kenneth Chun-Hong Yap; Sandra Jose; Dey Parama; Gautam Sethi; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-18

3.  A Nano-MgO and Ionic Liquid-Catalyzed 'Green' Synthesis Protocol for the Development of Adamantyl-Imidazolo-Thiadiazoles as Anti-Tuberculosis Agents Targeting Sterol 14α-Demethylase (CYP51).

Authors:  Sebastian Anusha; Baburajeev Cp; Chakrabhavi Dhananjaya Mohan; Jessin Mathai; Shobith Rangappa; Surender Mohan; Shardul Paricharak; Lewis Mervin; Julian E Fuchs; Mahedra M; Andreas Bender; Kanchugarakoppal S Rangappa
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

4.  Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.

Authors:  C P Baburajeev; Chakrabhavi Dhananjaya Mohan; Shobith Rangappa; Daniel J Mason; Julian E Fuchs; Andreas Bender; Uri Barash; Israel Vlodavsky; Kanchugarakoppal S Rangappa
Journal:  BMC Cancer       Date:  2017-03-31       Impact factor: 4.430

5.  Novel Biphenyl Amines Inhibit Oestrogen Receptor (ER)-α in ER-Positive Mammary Carcinoma Cells.

Authors:  Basappa Basappa; Baburajeev Chumadathil Pookunoth; Mamatha Shinduvalli Kempasiddegowda; Rangappa Knchugarakoppal Subbegowda; Peter E Lobie; Vijay Pandey
Journal:  Molecules       Date:  2021-02-03       Impact factor: 4.411

6.  Investigation of NPB Analogs That Target Phosphorylation of BAD-Ser99 in Human Mammary Carcinoma Cells.

Authors:  Swamy Savvemala Girimanchanaika; Dukanya Dukanya; Ananda Swamynayaka; Divya Maldepalli Govindachar; Mahendra Madegowda; Ganga Periyasamy; Kanchugarakoppal Subbegowda Rangappa; Vijay Pandey; Peter E Lobie; Basappa Basappa
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

7.  Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway.

Authors:  Chakrabhavi Dhananjaya Mohan; V Srinivasa; Shobith Rangappa; Lewis Mervin; Surender Mohan; Shardul Paricharak; Sefer Baday; Feng Li; Muthu K Shanmugam; Arunachalam Chinnathambi; M E Zayed; Sulaiman Ali Alharbi; Andreas Bender; Gautam Sethi; Kanchugarakoppal S Rangappa
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

8.  Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.

Authors:  Anilkumar C Nirvanappa; Chakrabhavi Dhananjaya Mohan; Shobith Rangappa; Hanumappa Ananda; Alexey Yu Sukhorukov; Muthu K Shanmugam; Mahalingam S Sundaram; Siddaiah Chandra Nayaka; Kesturu S Girish; Arunachalam Chinnathambi; M E Zayed; Sulaiman Ali Alharbi; Gautam Sethi; Kanchugarakoppal S Rangappa
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

9.  Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast Cancer.

Authors:  Hyejin Ko; Jong Hyun Lee; Hyun Su Kim; Taewoo Kim; Young Taek Han; Young-Ger Suh; Jaemoo Chun; Yeong Shik Kim; Kwang Seok Ahn
Journal:  Biomolecules       Date:  2019-05-03

Review 10.  Estrogen alpha receptor antagonists for the treatment of breast cancer: a review.

Authors:  Deepika Sharma; Sanjiv Kumar; Balasubramanian Narasimhan
Journal:  Chem Cent J       Date:  2018-10-25       Impact factor: 4.215

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.